Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001070451 | SCV001235682 | pathogenic | Charcot-Marie-Tooth disease, type I | 2019-12-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect MPZ protein function (PMID: 20461396). This variant has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 11080237, 12402337). ClinVar contains an entry for this variant (Variation ID: 14184). This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with valine at codon 75 of the MPZ protein (p.Asp75Val). The aspartic acid residue is highly conserved and there is a large physicochemical difference between aspartic acid and valine. |
OMIM | RCV000015248 | SCV000035507 | pathogenic | Charcot-Marie-Tooth disease type 2J | 2000-12-01 | no assertion criteria provided | literature only | |
Gene |
RCV000190346 | SCV000055674 | not provided | Charcot-Marie-Tooth disease type 1B | no assertion provided | literature only |